☰

Nicole M. Sodir, Ph.D. - Publications

Affiliations: 
2006 University of Southern California, Los Angeles, CA, United States 
Area:
Molecular Biology, Genetics, Oncology
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sodir NM, Pathria G, Adamkewicz JI, Kelley EH, Sudhamsu J, Merchant M, Chiarle R, Maddalo D. SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment. Cancer Discovery. OF1-OF17. PMID 37682219 DOI: 10.1158/2159-8290.CD-23-0383  0.451
2023 Antal CE, Oh TG, Aigner S, Luo EC, Yee BA, Campos T, Tiriac H, Rothamel KL, Cheng Z, Jiao H, Wang A, Hah N, Lenkiewicz E, Lumibao JC, Truitt ML, ... ... Sodir NM, et al. A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. Nature Communications. 14: 5195. PMID 37673892 DOI: 10.1038/s41467-023-40798-6  0.339
2022 Sodir NM, Pellegrinet L, Kortlever RM, Campos T, Kwon YW, Kim S, Garcia D, Perfetto A, Anastasiou P, Swigart LB, Arends MJ, Littlewood TD, Evan GI. Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution. Nature Communications. 13: 6782. PMID 36351945 DOI: 10.1038/s41467-022-34079-x  0.378
2020 Sodir NM, Kortlever RM, Barthet VJA, Campos T, Pellegrinet L, Kupczak S, Anastasiou P, Brown Swigart L, Soucek L, Arends MJ, Littlewood TD, Evan GI. Myc instructs and maintains pancreatic adenocarcinoma phenotype. Cancer Discovery. PMID 31941709 DOI: 10.1158/2159-8290.Cd-19-0435  0.5
2019 Sodir NM, Kortlever RM, Barthet VJA, Pellegrinet L, Campos T, Kupczak S, Soucek L, Arends MJ, Littlewood TD, Evan GI. Abstract LB-034: Myc instructs and maintains pancreatic adenocarcinoma phenotype Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Lb-034  0.533
2017 Kortlever RM, Sodir NM, Wilson CH, Burkhart DL, Pellegrinet L, Brown Swigart L, Littlewood TD, Evan GI. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 171: 1301-1315.e14. PMID 29195074 DOI: 10.1016/J.Cell.2017.11.013  0.396
2017 Evan GI, Hah N, Littlewood TD, Sodir NM, Campos T, Downes M, Evans RM. Re-engineering the Pancreas Tumor Microenvironment: A "Regenerative Program" Hacked. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 1647-1655. PMID 28373363 DOI: 10.1158/1078-0432.Ccr-16-3275  0.567
2016 Kortlever RM, Sodir NM, Wilson CH, Burkhart DL, Swigart L, Littlewood TD, Evan GI. Abstract 535: Deregulated Myc is an immunosuppressive switch Cancer Research. 76: 535-535. DOI: 10.1158/1538-7445.Am2016-535  0.53
2015 Escobar D, Hepp MI, Farkas C, Campos T, Sodir NM, Morales M, Álvarez CI, Swigart L, Evan GI, Gutiérrez JL, Nishinakamura R, Castro AF, Pincheira R. Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin. Cell Death & Disease. 6: e1816. PMID 26181197 DOI: 10.1038/Cddis.2015.165  0.345
2015 Massó-Vallés D, Jauset T, Serrano E, Sodir NM, Pedersen K, Affara NI, Whitfield JR, Beaulieu ME, Evan GI, Elias L, Arribas J, Soucek L. Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma. Cancer Research. 75: 1675-81. PMID 25878147 DOI: 10.1158/0008-5472.Can-14-2852  0.428
2015 Sodir NM, Swigart LB, Kortlever RM, Littlewood TD, Soucek L, Arends MJ, Evan GI. Abstract B09: Myc is required for maintenance of KRasG12D-driven pancreatic cancer and its associated microenvironment Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-B09  0.632
2015 Sodir NM, Soucek L, Littlewood TD, Arends MJ, Evan GI. Abstract A52: Myc is required for maintenance of KRasG12D-driven pancreatic cancer and its associated microenvironment Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A52  0.637
2015 Massó-Vallés D, Jauset T, Serrano E, Sodir NM, Pedersen K, Affara NI, Whitfield JR, Beaulieu M, Evan GI, Elias L, Arribas J, Soucek L. Abstract 396: Ibrutinib exerts potent antifibrotic activity in a mouse model of pancreatic adenocarcinoma Cancer Research. 75: 396-396. DOI: 10.1158/1538-7445.Am2015-396  0.392
2014 Annibali D, Whitfield JR, Favuzzi E, Jauset T, Serrano E, Cuartas I, Redondo-Campos S, Folch G, Gonzàlez-Juncà A, Sodir NM, Massó-Vallés D, Beaulieu ME, Swigart LB, Mc Gee MM, Somma MP, et al. Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis. Nature Communications. 5: 4632. PMID 25130259 DOI: 10.1038/Ncomms5632  0.393
2013 Sodir NM, Soucek L. The Myc world within reach. Methods in Molecular Biology (Clifton, N.J.). 1012: 1-6. PMID 24006054 DOI: 10.1007/978-1-62703-429-6_1  0.492
2013 Soucek L, Whitfield JR, Sodir NM, Massó-Vallés D, Serrano E, Karnezis AN, Swigart LB, Evan GI. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes & Development. 27: 504-13. PMID 23475959 DOI: 10.1101/Gad.205542.112  0.531
2013 Massó-Vallés D, Serrano E, Whitfield JR, Buggy JJ, Sodir NM, Affara NI, Swigart LB, Evan GI, Soucek L. Abstract 4956: Pharmacological inhibition of Bruton's Tyrosine Kinase (BTK) as a therapy for insulinoma and pancreatic ductal adenocarcinoma. Cancer Research. 73: 4956-4956. DOI: 10.1158/1538-7445.Am2013-4956  0.585
2012 Soucek L, Masso-Valles D, Jauset T, Whitfield JR, Buggy JJ, Sodir NM, Kortlever R, Swigart LB, Evan GI. 916 Modeling Pharmacological Inhibition of Bruton's Tyrosine Kinase (BTK) as a Therapy for Insulinoma and Pancreatic Ductal Adenocarcinoma European Journal of Cancer. 48. DOI: 10.1016/S0959-8049(12)71545-9  0.302
2012 Soucek L, Whitfield JR, Sodir NM, Masso-Valles D, Swigart LB, Evan GI. 749 Myc – a Non Redundant Function in Cancer European Journal of Cancer. 48. DOI: 10.1016/S0959-8049(12)71385-0  0.35
2011 Sodir NM, Evan GI. Finding cancer's weakest link. Oncotarget. 2: 1307-13. PMID 22202195 DOI: 10.18632/Oncotarget.396  0.456
2011 Sodir NM, Swigart LB, Karnezis AN, Hanahan D, Evan GI, Soucek L. Endogenous Myc maintains the tumor microenvironment. Genes & Development. 25: 907-16. PMID 21478273 DOI: 10.1101/Gad.2038411  0.553
2011 Oghamian S, Sodir NM, Bashir MU, Shen H, Cullins AE, Carroll CA, Kundu P, Shibata D, Laird PW. Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice. Carcinogenesis. 32: 829-35. PMID 21362628 DOI: 10.1093/Carcin/Bgr039  0.496
2008 Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, Karnezis AN, Swigart LB, Nasi S, Evan GI. Modelling Myc inhibition as a cancer therapy. Nature. 455: 679-83. PMID 18716624 DOI: 10.1038/Nature07260  0.405
2007 Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, Sodir NM, Chen YH, Josef-Lenz H, Laird PW, Clarke S, Mato JM, Lu SC. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology. 133: 207-18. PMID 17631143 DOI: 10.1053/J.Gastro.2007.03.114  0.554
2006 Sodir NM, Chen X, Park R, Nickel AE, Conti PS, Moats R, Bading JR, Shibata D, Laird PW. Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Research. 66: 8430-8. PMID 16951153 DOI: 10.1158/0008-5472.Can-06-1437  0.625
1998 Gali-Muhtasib HU, Haddadin MJ, Nazer MZ, Sodir NM, Maalouf SW. Photoprotective effects of some quinoxaline 1,4-dioxides in hairless mice. Medical Oncology (Northwood, London, England). 15: 262-9. PMID 9951690 DOI: 10.1007/Bf02787210  0.301
Show low-probability matches.